Literature DB >> 18937790

Production and characterization of monoclonal antibodies against major histocompatibility complex class I chain-related gene A.

W Wongsena1, G Sconocchia, H S Cho, C-C Chang, X Wang, K Klumkrathok, S Ferrone, C Leelayuwat.   

Abstract

Major histocompatibility complex (MHC) class I chain-related gene A (MICA), a ligand for the activating immunoreceptor natural killer group 2D (NKG2D), is expressed on stressed cells such as tumor cells. Study of expression of this molecule on tumor cells and patients' sera is useful to define patients' stages leading to proper selection of therapy. In this study, mouse anti-MICA monoclonal antibodies (mAbs) were produced by DNA immunization using a gene gun. Screening of anti-MICA-producing mouse and hybridomas were performed by immunoblot and cell enzyme-linked immunosorbent assay (ELISA) against MICA-positive HeLa and -negative Me1386 cell lines. MAbs were characterized against MICA-positive and -negative cell lines by immunoblot, cell ELISA and flow cytometry. The mAbs were also characterized for locus and allele specificities of MICA and MHC class I chain-related gene B (MICB) as well as for their ability to stain formalin-fixed paraffin-embedded tissues by immunohistochemistry. Although all mouse immune sera were positive with MICA-positive cells by both immunoblot and cell ELISA methods, some hybridomas were positive only with one method. The mAbs had diverse specificities to detect MICA and MICB and different abilities to stain formalin-fixed paraffin-embedded tissues. Thus, DNA immunization by gene gun is an effective method to generate immune mice for the production of mAbs with a variety of specificities against native and denatured forms of MIC proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18937790      PMCID: PMC3426284          DOI: 10.1111/j.1399-0039.2008.01118.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  35 in total

Review 1.  MIC genes: from genetics to biology.

Authors:  S Bahram
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

2.  Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.

Authors:  Dan H Barouch; Sampa Santra; Klara Tenner-Racz; Paul Racz; Marcelo J Kuroda; Joern E Schmitz; Shawn S Jackson; Michelle A Lifton; Dan C Freed; Helen C Perry; Mary-Ellen Davies; John W Shiver; Norman L Letvin
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

3.  MICB typing by PCR amplification with sequence specific primers.

Authors:  Segundo González; Sandra Rodríguez-Rodero; Jesús Martínez-Borra; Antonio López-Vázquez; Luis Rodrigo; Carlos López-Larrea
Journal:  Immunogenetics       Date:  2003-03-06       Impact factor: 2.846

4.  The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine.

Authors:  K Kusakabe; K Q Xin; H Katoh; K Sumino; E Hagiwara; S Kawamoto; K Okuda; Y Miyagi; I Aoki; K Nishioka; D Klinman; K Okuda
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

5.  Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.

Authors:  Daniela Pende; Paola Rivera; Stefania Marcenaro; Chien-Chung Chang; Roberto Biassoni; Romana Conte; Marek Kubin; David Cosman; Soldano Ferrone; Lorenzo Moretta; Alessandro Moretta
Journal:  Cancer Res       Date:  2002-11-01       Impact factor: 12.701

6.  Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice.

Authors:  Anne C Moore; Wing-pui Kong; Bimal K Chakrabarti; Gary J Nabel
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Diversity of MICA (PERB11.1) and HLA haplotypes in Northeastern Thais.

Authors:  A V Romphruk; T K Naruse; A Romphruk; H Kawata; C Puapairoj; J K Kulski; C Leelayuwat; H Inoko
Journal:  Tissue Antigens       Date:  2001-08

8.  Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.

Authors:  Veronika Groh; Jennifer Wu; Cassian Yee; Thomas Spies
Journal:  Nature       Date:  2002-10-17       Impact factor: 49.962

9.  Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding.

Authors:  Helmut R Salih; Hans-Georg Rammensee; Alexander Steinle
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

10.  Associations of MICB with cervical cancer in north-eastern Thais: identification of major histocompatibility complex class I chain-related gene B motifs influencing natural killer cell activation.

Authors:  A Jumnainsong; P Jearanaikoon; S Khahmahpahte; W Wongsena; A V Romphruk; B Chumworathayi; K Vaeteewoottacharn; M Ponglikitmongkol; A Romphruk; C Leelayuwat
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

View more
  6 in total

1.  Allelic MHC class I chain related B (MICB) molecules affect the binding to the human cytomegalovirus (HCMV) unique long 16 (UL16) protein: implications for immune surveillance.

Authors:  Kanya Klumkrathok; Amonrat Jumnainsong; Chanvit Leelayuwat
Journal:  J Microbiol       Date:  2013-04-27       Impact factor: 3.422

2.  Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma.

Authors:  Giuseppe Sconocchia; Inti Zlobec; Alessandro Lugli; Diego Calabrese; Giandomenica Iezzi; Eva Karamitopoulou; Efstratios S Patsouris; George Peros; Milo Horcic; Luigi Tornillo; Markus Zuber; Raoul Droeser; Manuele G Muraro; Chantal Mengus; Daniel Oertli; Soldano Ferrone; Luigi Terracciano; Giulio C Spagnoli
Journal:  Int J Cancer       Date:  2010-10-13       Impact factor: 7.396

3.  Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas.

Authors:  Helen P Cathro; Mark E Smolkin; Dan Theodorescu; Vickie Y Jo; Soldano Ferrone; Henry F Frierson
Journal:  Cancer Immunol Immunother       Date:  2009-09-16       Impact factor: 6.968

4.  Doxorubicin-conjugated bacteriophages carrying anti-MHC class I chain-related A for targeted cancer therapy in vitro.

Authors:  Achara Phumyen; Siriporn Jantasorn; Amonrat Jumnainsong; Chanvit Leelayuwat
Journal:  Onco Targets Ther       Date:  2014-11-28       Impact factor: 4.147

5.  Improved binding activity of antibodies against major histocompatibility complex class I chain-related gene A by phage display technology for cancer-targeted therapy.

Authors:  Achara Phumyen; Amonrat Jumnainsong; Chanvit Leelayuwat
Journal:  J Biomed Biotechnol       Date:  2012-11-21

Review 6.  DNA immunization as a technology platform for monoclonal antibody induction.

Authors:  Shuying Liu; Shixia Wang; Shan Lu
Journal:  Emerg Microbes Infect       Date:  2016-04-06       Impact factor: 7.163

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.